Published in Biochem J on January 15, 1988
Sequential effects of interleukin 2-diphtheria toxin fusion protein on T-cell activation. Proc Natl Acad Sci U S A (1989) 0.88
Inhibition of Nb2 T-lymphoma cell growth by transforming growth factor-beta. Biochem J (1988) 0.76
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J Biol Chem (1982) 16.71
The interleukin-2 T-cell system: a new cell growth model. Science (1984) 5.81
Sequential expression of protooncogenes during lectin-stimulated mitogenesis of normal human lymphocytes. Proc Natl Acad Sci U S A (1986) 3.19
Interleukin-2 induction of T-cell G1 progression and c-myb expression. Science (1986) 2.26
Interleukin-2 stimulates association of protein kinase C with plasma membrane. Nature (1985) 1.96
Prolactin receptors on human T and B lymphocytes: antagonism of prolactin binding by cyclosporine. J Immunol (1985) 1.47
Immunomodulation by bromocriptine. Immunopharmacology (1983) 1.42
A new sensitive and specific bioassay for lactogenic hormones: measurement of prolactin and growth hormone in human serum. J Clin Endocrinol Metab (1980) 1.39
Recombinant interleukin 2 regulates levels of c-myc mRNA in a cloned murine T lymphocyte. Mol Cell Biol (1985) 1.33
Regulation of immunity in rats by lactogenic and growth hormones. Acta Endocrinol (Copenh) (1983) 1.28
Production of immune interferon by an interleukin 2-independent murine T cell line. Proc Natl Acad Sci U S A (1982) 1.16
Prolactin as a modulator of lymphocyte responsiveness provides a possible mechanism of action for cyclosporine. Proc Natl Acad Sci U S A (1986) 1.07
Receptor-mediated mitogenic action of prolactin in a rat lymphoma cell line. Endocrinology (1983) 1.00
Phorbol myristate acetate and in vitro T lymphocyte function. I. PMA may contaminate lymphokine preparations and can interfere with interleukin bioassays. J Immunol (1983) 0.94
Cyclosporine inhibits prolactin induction of ornithine decarboxylase in rat tissues. Mol Cell Endocrinol (1984) 0.92
Interleukin 2 (IL-2) rapidly induces phosphorylation of a cellular protein, pp67, in an IL-2 dependent murine cell line. Biochem Biophys Res Commun (1986) 0.87
Thymic origin of the prolactin-dependent Nb2 lymphoma cell line. Cancer Res (1982) 0.86
Interleukin 2 rapidly stimulates synthesis and breakdown of polyphosphoinositides in interleukin 2-dependent, murine T-cell lines. J Biol Chem (1987) 0.85
Interleukin 2 modulation of adenylate cyclase. Potential role of protein kinase C. J Biol Chem (1986) 0.84
Prolactin-induced polyamine biosynthesis in spleen and thymus: specific inhibition by cyclosporine. Immunopharmacology (1985) 0.84
Biochemical response of lymphoma cells to mitogenic stimulation by prolactin. Mol Cell Endocrinol (1982) 0.83
Studies on T lymphocyte activation. II. Monoclonal antibody inhibiting the capacity of rat T lymphoblasts to absorb and to respond to IL-2: an anti-IL-2 receptor antibody? Immunology (1983) 0.82
Human growth hormone induces and maintains c-myc gene expression in Nb2 lymphoma cells. Endocrinology (1985) 0.81
Enhancement of human growth hormone-stimulated mitogenesis of Nb2 node lymphoma cells by 12-O-tetradecanoyl-phorbol-13-acetate. Endocrinology (1985) 0.81
Interleukin 2 induces rapid phosphorylation of cellular proteins in murine T-lymphocytes. FEBS Lett (1986) 0.81
Prolactin stimulation of ornithine decarboxylase and mitogenesis in Nb2 node lymphoma cells: the role of protein kinase C and calcium mobilization. Immunopharmacology (1986) 0.80
Regulation of 70-kilodalton heat-shock-like messenger ribonucleic acid in vitro and in vivo by prolactin. Mol Endocrinol (1987) 0.80
Role of ornithine decarboxylase in proliferation of prolactin-dependent lymphoma cells. Biochem Cell Biol (1986) 0.77
Prolactin stimulation of Nb 2 node lymphoma cell division is inhibited by polyamine biosynthesis inhibitors. Proc Soc Exp Biol Med (1985) 0.77
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology (1991) 23.01
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology (1989) 16.83
Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N Engl J Med (2010) 12.08
Biological and virologic characteristics of primary HIV infection. Ann Intern Med (1998) 5.45
A prospective study of risk factors for symptomatic urinary tract infection in young women. N Engl J Med (1996) 4.69
Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection. J Infect Dis (2000) 3.36
Effects of electronic fetal-heart-rate monitoring, as compared with periodic auscultation, on the neurologic development of premature infants. N Engl J Med (1990) 3.04
Association between culturable human immunodeficiency virus type 1 (HIV-1) in semen and HIV-1 RNA levels in semen and blood: evidence for compartmentalization of HIV-1 between semen and blood. J Infect Dis (1998) 2.98
Sexual mixing patterns of patients attending sexually transmitted diseases clinics. Sex Transm Dis (1996) 2.76
Sexual mixing patterns in the spread of gonococcal and chlamydial infections. Am J Public Health (1999) 2.54
Logistic regression when the outcome is measured with uncertainty. Am J Epidemiol (1997) 2.49
Interlaboratory comparison of neuropathology assessments in Alzheimer's disease: a study of the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) J Neuropathol Exp Neurol (1994) 2.34
Genetic analysis of an inherited predisposition to colon cancer in a family with a variable number of adenomatous polyps. N Engl J Med (1990) 2.32
Detection and staging of dementia in Alzheimer's disease. Use of the neuropsychological measures developed for the Consortium to Establish a Registry for Alzheimer's Disease. Arch Neurol (1992) 2.19
Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia. J Natl Cancer Inst (1997) 2.06
Perforation of the bladder: a complication of long-dwelling Foley catheter. J Urol (1973) 2.05
Concurrent and sequential acquisition of different genital human papillomavirus types. J Infect Dis (2000) 1.87
B cell-stimulatory factor 1 (BSF-1) promotes growth of helper T cell lines. J Exp Med (1986) 1.82
Comparative epidemiology of heterosexual gonococcal and chlamydial networks: implications for transmission patterns. Sex Transm Dis (2000) 1.82
Stimulation of DNA synthesis in mouse lymphoid cells by polyanions in vitro. I. Target cells and possible mode of action. Eur J Immunol (1973) 1.80
High risk of human immunodeficiency virus in men who have sex with men with herpes simplex virus type 2 in the EXPLORE study. Am J Epidemiol (2006) 1.70
Syndromic management of STDs in pharmacies: evaluation and randomised intervention trial. Sex Transm Infect (1998) 1.69
The effects of prenatal diagnosis, population ageing, and changing fertility rates on the live birth prevalence of Down syndrome in New York State, 1983-1992. Prenat Diagn (1996) 1.68
Analysis of cytokine mRNA levels in interleukin-4-transgenic mice by quantitative polymerase chain reaction. Eur J Immunol (1992) 1.67
Stimulation of humoral antibody formation by polyanions. 3. Restoration of the immune response to sheep red blood cells by polyanions in thymectomized and lethally irradiated mice protected with bone marrow cells. Eur J Immunol (1971) 1.66
Tumor suppression after tumor cell-targeted tumor necrosis factor alpha gene transfer. J Exp Med (1991) 1.66
Radiological evaluation and management of malfunctioning central venous catheters. Clin Radiol (1998) 1.65
Interleukin 7 induces CD4+ T cell-dependent tumor rejection. J Exp Med (1991) 1.64
Stimulation of humoral antibody formation by polyanions. I. The effect of polyacrylic acid on the primary immune response in mice immunized with sheep red blood cells. Eur J Immunol (1971) 1.61
A rat monoclonal antibody that binds specifically to mouse T lymphoblasts and inhibits IL 2 receptor functions: a putative anti-IL 2 receptor antibody. J Immunol (1984) 1.58
Citation analysis of otorhinolaryngology journals. J Laryngol Otol (2002) 1.58
A randomized trial of electronic fetal monitoring in preterm labor. Obstet Gynecol (1987) 1.54
Stimulation of humoral antibody formation by polyanions. II. The influence of sulfate esters of polymers on the immune response in mice. Eur J Immunol (1971) 1.52
The antagonistic action of cyclic GMP and cyclic AMP on proliferation of B and T lymphocytes. Immunology (1975) 1.51
Avoiding risky sex partners: perception of partners' risks v partners' self reported risks. Sex Transm Infect (2003) 1.49
Interleukin 2 receptor in patients with localized and systemic parasitic diseases. Clin Exp Immunol (1988) 1.49
Estrogen replacement and coronary artery disease. Effect on survival in postmenopausal women. Arch Intern Med (1990) 1.48
Early and persistent human immunodeficiency virus type 1 (HIV-1)-specific T helper dysfunction in blood and lymph nodes following acute HIV-1 infection. J Infect Dis (1999) 1.47
Decline in the growth potential of spleen-colonizing bone marrow stem cells of long-lived aging mice. J Exp Med (1976) 1.41
Nucleotide sequence of mouse IL-2 receptor cDNA and its comparison with the human IL-2 receptor sequence. Nucleic Acids Res (1985) 1.40
Medial orbital wall blow-out fracture producing an acquired retraction syndrome. J Clin Neuroophthalmol (1986) 1.39
Sexually transmitted diseases in men who have sex with men. Acquisition of gonorrhea and nongonococcal urethritis by fellatio and implications for STD/HIV prevention. Sex Transm Dis (1997) 1.38
The characteristics of a monoclonal antibody that binds specifically to rat T lymphoblasts and inhibits IL 2 receptor functions. J Immunol (1983) 1.36
Suppression of the primary immune response in vivo to sheep red blood cells by B-cell mitogens. Immunology (1976) 1.31
Differences in resistance to Trypanosoma musculi infection among strains of inbred mice. Infect Immun (1981) 1.31
Amyloid beta-peptide(1-42) and hydrogen peroxide-induced toxicity are mediated by TRPM2 in rat primary striatal cultures. J Neurochem (2005) 1.30
Polyanions and lipopolysaccharide acts on different subpopulations of B cells. Nature (1974) 1.28
Mechanisms of rejection induced by tumor cell-targeted gene transfer of interleukin 2, interleukin 4, interleukin 7, tumor necrosis factor, or interferon gamma. Proc Natl Acad Sci U S A (1993) 1.27
Retroviral expression of the human IL-2 gene in a murine T cell line results in cell growth autonomy and tumorigenicity. EMBO J (1987) 1.26
Monoclonal antibodies identify three epitope clusters on the mouse p55 subunit of the interleukin 2 receptor: relationship to the interleukin 2-binding site. Eur J Immunol (1987) 1.25
Trypanosome-induced splenomegaly and suppression of mouse spleen cell responses to antigen and mitogens. J Reticuloendothel Soc (1977) 1.24
The accuracy of citation and quotation in otolaryngology/head and neck surgery journals. Clin Otolaryngol Allied Sci (2000) 1.24
Stimulation of B-cells by dextran sulphate in vitro. Immunology (1973) 1.23
Control of the immune response in vitro by calcium ions. I. The antagonistic action of calcium ions on cell proliferation and on cell differentiation. Immunology (1974) 1.22
Therapy with monoclonal antibody to interleukin 2 receptor spares suppressor T cells and prevents or reverses acute allograft rejection in rats. Proc Natl Acad Sci U S A (1986) 1.21
Publication rates of scientific papers presented at the Otorhinolarygological Research Society meetings. Clin Otolaryngol Allied Sci (2001) 1.20
Interleukin 2-dependent and interleukin 2-independent pathways of regulation of thymocyte function by interleukin 6. Proc Natl Acad Sci U S A (1988) 1.19
Lack of tumorigenicity of interleukin 4 autocrine growing cells seems related to the anti-tumor function of interleukin 4. Mol Immunol (1990) 1.19
Interleukin 10 transfected into Chinese hamster ovary cells prevents tumor growth and macrophage infiltration. Cancer Res (1993) 1.19
Mechanisms of trypanosome-mediated suppression of humoral immunity in mice. Proc Natl Acad Sci U S A (1978) 1.18
Interleukin 2 receptors are released by cells in vitro and in vivo. I. Detection of soluble IL 2 receptors in cell culture supernatants and in the serum of mice by an immunoradiometric assay. Eur J Immunol (1986) 1.17
Expression of interleukin 10 in human melanoma. Br J Cancer (1994) 1.15
A century of citation classics in otolaryngology-head and neck Surgery journals. J Laryngol Otol (2002) 1.15
The nature and regulation of the receptors for pituitary growth hormone. Annu Rev Physiol (1985) 1.13
Identification of IL 2R+ T cells and macrophages within rejecting rat cardiac allografts, and comparison of the effects of treatment with anti-IL 2R monoclonal antibody or cyclosporin. J Immunol (1987) 1.13
Stimulation of DNA synthesis in mouse lymphoid cells by polyanions in vitro. II. Relationship between adjuvant activity and stimulation of DNA synthesis by polyanions. Eur J Immunol (1973) 1.12
Pathways of human exposure to arsenic in a community surrounding a copper smelter. Environ Res (1990) 1.11
TCGF(IL 2)-receptor inducing factor(s). II. Possible role of ATL-derived factor (ADF) on constitutive IL 2 receptor expression of HTLV-I(+) T cell lines. J Immunol (1985) 1.11
Epidemiology of holoprosencephaly and phenotypic characteristics of affected children: New York State, 1984-1989. Am J Med Genet (1997) 1.10
The validity of 3 clinical diagnostic criteria for Alzheimer's disease. Neurology (1990) 1.09
Dynamic regulation of spinal pro-inflammatory cytokine release in the rat in vivo following peripheral nerve injury. Brain Behav Immun (2009) 1.08
Analysis of growth hormone and lactogenic binding sites cross-linked to iodinated human growth hormone. Endocrinology (1983) 1.07
HLA class II DR-DQ and increased risk of cervical cancer among Senegalese women. Cancer Epidemiol Biomarkers Prev (2001) 1.07
Generation of competitor DNA fragments for quantitative PCR. PCR Methods Appl (1991) 1.07
Product limit estimation for infectious disease data when the diagnostic test for the outcome is measured with uncertainty. Biostatistics (2000) 1.07
The decline of immunological resistance of aging mice to Trypanosoma musculi. Mech Ageing Dev (1982) 1.06
Induction of interleukin 2 responsiveness in thymocytes by synergistic action of interleukin 1 and interleukin 2. J Immunol (1985) 1.05
Interaction between Entamoeba histolytica and the immune system. I. Mitogenicity of Entamoeba histolytica extracts for human peripheral T lymphocytes. J Immunol (1981) 1.05
Postmenopausal estrogen use and coronary atherosclerosis. Ann Intern Med (1988) 1.05
Inhibition of murine humoral immune responses by substances derived from trypanosomes. J Immunol (1981) 1.04
Detection and localization by the monoclonal anti-interleukin 2 receptor antibody AMT-13 of IL 2 receptor-bearing cells in the developing thymus of the mouse embryo and in the thymus of cortisone-treated mice. Eur J Immunol (1984) 1.04
The control of immune response in vitro by Ca2+. II. The Ca2+-dependent period during mitogenic stimulation. Immunology (1975) 1.03
Antecedent antimicrobial use increases the risk of uncomplicated cystitis in young women. Clin Infect Dis (1997) 1.02
eNAP-2, a novel cysteine-rich bactericidal peptide from equine leukocytes. Infect Immun (1992) 1.02
Identification of eNAP-1, an antimicrobial peptide from equine neutrophils. Infect Immun (1992) 1.02
Postnasal drip causes cough and is associated with reversible upper airway obstruction. Chest (1984) 1.01
Identification and characterization of high and low affinity binding sites for growth hormone in rabbit liver. Endocrinology (1979) 1.01
Elevated titers of cell-free interleukin 2 receptor in serum of lupus mice. J Immunol (1987) 1.01
Stimulation of humoral antibody formation by polyanions. V. Relationship between enhancement of sheep red blood cell uptake by the spleen and adjuvant action of dextran sulfate. Eur J Immunol (1971) 1.01
Interleukin-4-mediated tumor suppression in nude mice involves interferon-gamma. Eur J Immunol (1992) 1.00
Gonadal dysgenesis in the mare. J Reprod Fertil Suppl (1975) 1.00
Relative susceptibilities of T cell subsets involved in delayed-type hypersensitivity to sheep red blood cells to the in vitro action of 4-hydroperoxycyclophosphamide. J Immunol (1980) 1.00
Partner management for gonococcal and chlamydial infection: expansion of public health services to the private sector and expedited sex partner treatment through a partnership with commercial pharmacies. Sex Transm Dis (2001) 1.00
The human intermediate-affinity interleukin 2 receptor consists of two distinct, partially homologous glycoproteins. Eur J Immunol (1988) 0.99
Expression of interleukin-6 and interleukin-6 receptor in Hodgkin's disease. Blood (1991) 0.99
The mouse high affinity IL 2 receptor complex. I. Evidence for a third molecule, the putative gamma-chain, associated with the alpha- and/or beta-chain of the receptor. Immunobiology (1987) 0.99
Reduced humoral immune activity in long-lived old mice: an approach to elucidating its mechanisms. Immunology (1976) 0.98